- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NXE: ~{N}-[3-(trifluoromethyl)-1,2-oxazol-5-yl]ethanamide(Non-covalent)
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
FBP.2: 16 residues within 4Å:- Chain A: L.448, T.449, K.450, S.451, R.453, S.454, W.499, R.506, G.531, R.533, P.534, G.535, S.536, G.537, F.538, T.539
16 PLIP interactions:16 interactions with chain A- Hydrogen bonds: A:T.449, A:K.450, A:S.451, A:G.452, A:R.453, A:S.454, A:S.454, A:G.531, A:G.535, A:S.536, A:G.537, A:F.538
- Water bridges: A:R.506, A:T.539
- Salt bridges: A:K.450, A:R.506
FBP.5: 16 residues within 4Å:- Chain B: L.448, T.449, K.450, S.451, R.453, S.454, W.499, R.506, G.531, R.533, P.534, G.535, S.536, G.537, F.538, T.539
16 PLIP interactions:16 interactions with chain B- Hydrogen bonds: B:T.449, B:K.450, B:S.451, B:G.452, B:R.453, B:S.454, B:S.454, B:G.531, B:G.535, B:S.536, B:G.537, B:F.538
- Water bridges: B:R.506, B:T.539
- Salt bridges: B:K.450, B:R.506
FBP.8: 16 residues within 4Å:- Chain C: L.448, T.449, K.450, S.451, R.453, S.454, W.499, R.506, G.531, R.533, P.534, G.535, S.536, G.537, F.538, T.539
18 PLIP interactions:18 interactions with chain C- Hydrogen bonds: C:T.449, C:K.450, C:S.451, C:G.452, C:R.453, C:S.454, C:S.454, C:S.454, C:G.531, C:G.535, C:S.536, C:G.537, C:F.538
- Water bridges: C:R.506, C:T.539, C:T.539
- Salt bridges: C:K.450, C:R.506
FBP.11: 16 residues within 4Å:- Chain D: L.448, T.449, K.450, S.451, R.453, S.454, W.499, R.506, G.531, R.533, P.534, G.535, S.536, G.537, F.538, T.539
18 PLIP interactions:18 interactions with chain D- Hydrogen bonds: D:T.449, D:K.450, D:S.451, D:G.452, D:R.453, D:S.454, D:S.454, D:S.454, D:G.531, D:G.535, D:S.536, D:G.537, D:F.538
- Water bridges: D:R.506, D:T.539, D:T.539
- Salt bridges: D:K.450, D:R.506
- 4 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.3: 4 residues within 4Å:- Chain A: L.370, I.406, Y.407
- Ligands: NXE.1
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Y.407
DMS.6: 4 residues within 4Å:- Chain B: L.370, I.406, Y.407
- Ligands: NXE.4
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Y.407
DMS.9: 4 residues within 4Å:- Chain C: L.370, I.406, Y.407
- Ligands: NXE.7
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Y.407
DMS.12: 4 residues within 4Å:- Chain D: L.370, I.406, Y.407
- Ligands: NXE.10
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:Y.407
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Saur, M. et al., Fragment-based drug discovery using cryo-EM. Drug Discov Today (2020)
- Release Date
- 2020-01-15
- Peptides
- Pyruvate kinase PKM: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NXE: ~{N}-[3-(trifluoromethyl)-1,2-oxazol-5-yl]ethanamide(Non-covalent)
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
- 4 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Saur, M. et al., Fragment-based drug discovery using cryo-EM. Drug Discov Today (2020)
- Release Date
- 2020-01-15
- Peptides
- Pyruvate kinase PKM: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D